...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): impact of vehicle for topical induction.
【24h】

Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): impact of vehicle for topical induction.

机译:布朗挪威大鼠哮喘的二苯甲烷-4,4'-二异氰酸酯(MDI)哮喘模型:载体对局部诱导的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The development of this Brown Norway (BN) rat asthma model was focused on the duplication of at least some hallmarks of human diisocyanate asthma using the skin as the initial priming route of exposure. Equal total doses of polymeric diphenylmethane-diisocyanate (MDI) were applied to similar surface areas either dissolved in di-n-octyl sebacic acid ester (20%) (SEBA), in acetone:olive oil (20%) (AOO) or undiluted. The elicitation of respiratory allergy utilized four repeated nose-only inhalation challenges of 30 min with 39 mg/m(3) MDI-aerosol approximately every 2 weeks. Emphasis was directed towards the analysis of respiratory responses delayed in onset. Endpoints suggestive of an allergic inflammatory response were examined by bronchoalveolar lavage (BAL) 1 day after the last inhalation challenge and comprised protein, LDH, cytodifferentiation of BAL cells, MCP-1, and some Th1 and Th2 cytokines. MCP-1 and cytokines were comparatively determined in three compartments: BAL fluid, BAL cells, and lung-associated lymph nodes (LALN). In all groups sensitized topically to MDI typical delayed-onset respiratory responses occurred. The lung and LALN weights, BAL-protein and -LDH were significantly increased as compared to the naive control group challenged identically. There was compelling evidence of a neutrophilic rather than an eosinophilic inflammatory response. The patterns of interleukin (IL) IL-1alpha, TNF-alpha, IFN-gamma, GM-CSF, and IL-4 differed appreciably from one compartment to another and were essentially maximal in BAL cells. In contrast, MCP-1 was increased to the same extent in all compartments measured. Collectively, changes were slightly, although consistently more pronounced when using SEBA as vehicle when compared with the vehicle AOO or undiluted MDI. Notable was a discordance of cytokine profiles and respiratory responses. In conclusion, the priming potency of topically administered MDI and subsequent asthma-like responses following repeated inhalation exposures appear to be dependent on multiple factors, one of them appears to be associated with the type of matrix used to dissolve MDI. This animal model provides a versatile and robust experimental tool to evaluate and assess at least some features of MDI-related asthma.
机译:此布朗挪威(BN)大鼠哮喘模型的开发重点在于使用皮肤作为暴露的初始引发途径来复制人类二异氰酸酯哮喘的至少某些标志。将等剂量的聚合二苯基甲烷二异氰酸酯(MDI)应用于溶解在二正辛基癸二酸酯(20%)(SEBA),丙酮:橄榄油(20%)(AOO)或未稀释的相似表面积中。呼吸道过敏的诱发大约每2周利用四次重复的仅鼻子吸入挑战,持续30分钟,每次使用39 mg / m(3)MDI气雾剂。重点是针对延迟发作的呼吸系统反应进行分析。在最后一次吸入攻击后1天,通过支气管肺泡灌洗(BAL)检查了提示过敏性炎症反应的终点,包括蛋白质,LDH,BAL细胞的细胞分化,MCP-1以及一些Th1和Th2细胞因子。在三个部分中比较确定了MCP-1和细胞因子:BAL液,BAL细胞和与肺相关的淋巴结(LALN)。在对MDI局部敏感的所有组中,均发生典型的延迟发作呼吸反应。肺和LALN的重量,BAL蛋白和-LDH相比,相同的天真对照组都显着增加。有令人信服的证据表明是嗜中性而不是嗜酸性的炎症反应。白介素(IL)IL-1α,TNF-α,IFN-γ,GM-CSF和IL-4的模式在一个隔间之间明显不同,并且在BAL细胞中基本上是最大的。相反,在所有测得的隔室中,MCP-1的增加程度均相同。总体而言,变化很小,尽管与SEO或未稀释的MDI相比,当使用SEBA作为媒介时,变化更为明显。值得注意的是细胞因子谱和呼吸系统反应不一致。总之,在反复吸入后,局部给药的MDI的引发效力和随后的类似哮喘的反应似乎取决于多种因素,其中之一似乎与用于溶解MDI的基质类型有关。这种动物模型提供了一种通用且强大的实验工具,可以评估和评估MDI相关哮喘的至少某些特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号